Coincident with these findings, we examined Rac1/Cdc42 expression in 339 human breast cancer specimens and determined that high levels of Rac1/Cdc42 expression were correlated with advanced TNM staging and proliferation index (Ki-67 status) but not with Her2 status. Here, ERBB2 is linked to breast cancer.